FPCSX
Price
$47.32
Change
-$0.03 (-0.06%)
Updated
Aug 14 closing price
Net Assets
12.98B
GMIAX
Price
$10.90
Change
+$0.06 (+0.55%)
Updated
Aug 13 closing price
Net Assets
934.26M
Interact to see
Advertisement

FPCSX vs GMIAX

FPCSX vs GMIAX Comparison Chart in %
View a ticker or compare two or three
VS
FPCSX vs. GMIAX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FPCSX is a Buy and GMIAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FPCSX has more cash in the bank: 13B vs. GMIAX (934M). GMIAX pays higher dividends than FPCSX: GMIAX (4.11) vs FPCSX (2.59). FPCSX was incepted earlier than GMIAX: FPCSX (6 years) vs GMIAX (22 years). FPCSX (1.05) is less costly to investors than GMIAX (0.52). GMIAX is a more actively managed with annual turnover of: 33.63 vs. FPCSX (23.00). GMIAX has a lower initial minimum investment than FPCSX: GMIAX (1000000) vs FPCSX (100000000). GMIAX annual gain was more profitable for investors over the last year : 13.73 vs. FPCSX (9.98). FPCSX return over 5 years is better than : 23.76 vs. GMIAX (12.60).
FPCSXGMIAXFPCSX / GMIAX
Total Expense Ratio0.990.52190%
Annual Report Gross Expense Ratio1.050.52202%
Fund Existence6 years22 years-
Gain YTD9.88713.29774%
Front LoadN/AN/A-
Min. Initial Investment100000000100000010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13B934M1,392%
Annual Yield % from dividends2.594.1163%
Returns for 1 year9.9813.7373%
Returns for 3 years33.3527.05123%
Returns for 5 years23.7612.60189%
Returns for 10 yearsN/A34.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX34.20N/A
N/A
Fidelity Select Pharmaceuticals Port
TCVAX28.05N/A
N/A
Touchstone Mid Cap Value A
VTIAX46.95N/A
N/A
Vanguard Total Intl Stock Index Admiral
TIEWX17.64N/A
N/A
Nuveen International Eq W
FWOCX20.91N/A
N/A
Fidelity Advisor Women's Leadership C